MINI LONG - SANOFI Share Price

Certificat

BR30C

DE000KG7RR79

Real-time Euronext Paris 08:23:14 06/05/2024 BST
2.97 EUR +1.37% Intraday chart for MINI LONG - SANOFI
1 month+6.55%
3 months+7.33%
Date Price Change Volume
06/05/24 2.97 +1.37% 4
03/05/24 2.93 -2.01% 63
02/05/24 2.99 -3.55% 65
30/04/24 3.1 +3.68% 58
29/04/24 2.99 +2.05% 62

Real-time Euronext Paris

Last update May 06, 2024 at 08:23 am

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Citi Citi
BR30C
ISINDE000KG7RR79
Date issued 15/08/2022
Strike 62.06
Maturity Unlimited
Parity 10 : 1
Emission price 2.819
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 4.52
Lowest since issue 1.96

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
91.3 EUR
Average target price
108.1 EUR
Spread / Average Target
+18.36%
Consensus
  1. Stock Market
  2. Certificates
  3. BR30C Certificat